APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nicotinamide Tablets

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Nicotinamide Tablets Market Outlook and Growth Opportunities 2026

31 December 2025192 pages

Choose your research edition.

Industry ResearchNicotinamide Tablets Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Nicotinamide Tablets Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Nicotinamide Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nicotinamide Tablets Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Nicotinamide Tablets Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Nicotinamide Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Nicotinamide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Nicotinamide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nicotinamide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Nicotinamide Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Nicotinamide Tablets market include Puritan’s Pride, Swisse, CONBA, Shanghai Pharma, Century Huaxing Biological Engineering and Tianjin Lisheng Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Nicotinamide Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nicotinamide Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nicotinamide Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Nicotinamide Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Nicotinamide Tablets Segment by Company

Puritan’s Pride

Swisse

CONBA

Shanghai Pharma

Century Huaxing Biological Engineering

Tianjin Lisheng Pharmaceutical

Nicotinamide Tablets Segment by Type

50mg/Tablets

100mg/Tablets

Nicotinamide Tablets Segment by Application

Online Sales

Offline Sales

Nicotinamide Tablets Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Nicotinamide Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Nicotinamide Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Nicotinamide Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Nicotinamide Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nicotinamide Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nicotinamide Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nicotinamide Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Nicotinamide Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Nicotinamide Tablets industry.

Chapter 3: Detailed analysis of Nicotinamide Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Nicotinamide Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Nicotinamide Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Nicotinamide Tablets Industry Trends Table 2. Nicotinamide Tablets Industry Drivers Table 3. Nicotinamide Tablets Industry Opportunities and Challenges Table 4. Nicotinamide Tablets Industry Restraints Table 5. Global Nicotinamide Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Nicotinamide Tablets Revenue Share by Company (2021-2026) Table 7. Global Nicotinamide Tablets Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Nicotinamide Tablets Sales Volume Share by Company (2021-2026) Table 9. Global Nicotinamide Tablets Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Nicotinamide Tablets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Nicotinamide Tablets Key Company Manufacturing Base & Headquarters Table 12. Global Nicotinamide Tablets Company, Product Type & Application Table 13. Global Nicotinamide Tablets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Nicotinamide Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 50mg/Tablets Table 18. Significant Companies of 100mg/Tablets Table 19. Global Nicotinamide Tablets Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Nicotinamide Tablets Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Nicotinamide Tablets Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Nicotinamide Tablets Sales Volume Share by Type (2021-2026) Table 23. Global Nicotinamide Tablets Sales Volume Share by Type (2027-2032) Table 24. Global Nicotinamide Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Nicotinamide Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Nicotinamide Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Nicotinamide Tablets Sales Value Share by Type (2021-2026) Table 28. Global Nicotinamide Tablets Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Online Sales Table 30. Significant Companies of Offline Sales Table 31. Global Nicotinamide Tablets Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Nicotinamide Tablets Sales Volume by Application (2021-2026) & (K Units) Table 33. Global Nicotinamide Tablets Sales Volume by Application (2027-2032) & (K Units) Table 34. Global Nicotinamide Tablets Sales Volume Share by Application (2021-2026) Table 35. Global Nicotinamide Tablets Sales Volume Share by Application (2027-2032) Table 36. Global Nicotinamide Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Nicotinamide Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Nicotinamide Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Nicotinamide Tablets Sales Value Share by Application (2021-2026) Table 40. Global Nicotinamide Tablets Sales Value Share by Application (2027-2032) Table 41. Global Nicotinamide Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Nicotinamide Tablets Sales by Region (2021-2026) & (K Units) Table 43. Global Nicotinamide Tablets Sales Market Share by Region (2021-2026) Table 44. Global Nicotinamide Tablets Sales by Region (2027-2032) & (K Units) Table 45. Global Nicotinamide Tablets Sales Market Share by Region (2027-2032) Table 46. Global Nicotinamide Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Nicotinamide Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Nicotinamide Tablets Sales Value Share by Region (2021-2026) Table 49. Global Nicotinamide Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Nicotinamide Tablets Sales Value Share by Region (2027-2032) Table 51. Global Nicotinamide Tablets Market Average Price (US$/Unit) by Region (2021-2026) Table 52. Global Nicotinamide Tablets Market Average Price (US$/Unit) by Region (2027-2032) Table 53. Global Nicotinamide Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Global Nicotinamide Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Nicotinamide Tablets Sales by Country (2021-2026) & (K Units) Table 56. Global Nicotinamide Tablets Sales Market Share by Country (2021-2026) Table 57. Global Nicotinamide Tablets Sales by Country (2027-2032) & (K Units) Table 58. Global Nicotinamide Tablets Sales Market Share by Country (2027-2032) Table 59. Global Nicotinamide Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Nicotinamide Tablets Sales Value Market Share by Country (2021-2026) Table 61. Global Nicotinamide Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Nicotinamide Tablets Sales Value Market Share by Country (2027-2032) Table 63. Puritan’s Pride Company Information Table 64. Puritan’s Pride Business Overview Table 65. Puritan’s Pride Nicotinamide Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Puritan’s Pride Nicotinamide Tablets Product Portfolio Table 67. Puritan’s Pride Recent Development Table 68. Swisse Company Information Table 69. Swisse Business Overview Table 70. Swisse Nicotinamide Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Swisse Nicotinamide Tablets Product Portfolio Table 72. Swisse Recent Development Table 73. CONBA Company Information Table 74. CONBA Business Overview Table 75. CONBA Nicotinamide Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. CONBA Nicotinamide Tablets Product Portfolio Table 77. CONBA Recent Development Table 78. Shanghai Pharma Company Information Table 79. Shanghai Pharma Business Overview Table 80. Shanghai Pharma Nicotinamide Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Shanghai Pharma Nicotinamide Tablets Product Portfolio Table 82. Shanghai Pharma Recent Development Table 83. Century Huaxing Biological Engineering Company Information Table 84. Century Huaxing Biological Engineering Business Overview Table 85. Century Huaxing Biological Engineering Nicotinamide Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Century Huaxing Biological Engineering Nicotinamide Tablets Product Portfolio Table 87. Century Huaxing Biological Engineering Recent Development Table 88. Tianjin Lisheng Pharmaceutical Company Information Table 89. Tianjin Lisheng Pharmaceutical Business Overview Table 90. Tianjin Lisheng Pharmaceutical Nicotinamide Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Tianjin Lisheng Pharmaceutical Nicotinamide Tablets Product Portfolio Table 92. Tianjin Lisheng Pharmaceutical Recent Development Table 93. Key Raw Materials Table 94. Raw Materials Key Suppliers Table 95. Nicotinamide Tablets Distributors List Table 96. Nicotinamide Tablets Customers List Table 97. Research Programs/Design for This Report Table 98. Authors List of This Report Table 99. Secondary Sources Table 100. Primary Sources List of Figures Figure 1. Nicotinamide Tablets Product Image Figure 2. Global Nicotinamide Tablets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nicotinamide Tablets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Nicotinamide Tablets Sales (2021-2032) & (K Units) Figure 5. Global Nicotinamide Tablets Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Nicotinamide Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 50mg/Tablets Image Figure 10. 100mg/Tablets Image Figure 11. Global Nicotinamide Tablets Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Nicotinamide Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Nicotinamide Tablets Sales Volume Share by Type (2021-2032) Figure 14. Global Nicotinamide Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Nicotinamide Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Nicotinamide Tablets Sales Value Share by Type (2021-2032) Figure 17. Online Sales Image Figure 18. Offline Sales Image Figure 19. Global Nicotinamide Tablets Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Nicotinamide Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Nicotinamide Tablets Sales Volume Share by Application (2021-2032) Figure 22. Global Nicotinamide Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Nicotinamide Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Nicotinamide Tablets Sales Value Share by Application (2021-2032) Figure 25. Global Nicotinamide Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 26. Global Nicotinamide Tablets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Nicotinamide Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Nicotinamide Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Nicotinamide Tablets Sales Value (2021-2032) & (US$ Million) Figure 30. North America Nicotinamide Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Nicotinamide Tablets Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Nicotinamide Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Nicotinamide Tablets Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Nicotinamide Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Nicotinamide Tablets Sales Value (2021-2032) & (US$ Million) Figure 36. South America Nicotinamide Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Nicotinamide Tablets Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Nicotinamide Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Nicotinamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Nicotinamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Nicotinamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Nicotinamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Nicotinamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Nicotinamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Nicotinamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Nicotinamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Nicotinamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Nicotinamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Nicotinamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Nicotinamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Nicotinamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Nicotinamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Nicotinamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Nicotinamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Nicotinamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Nicotinamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Nicotinamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Nicotinamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Nicotinamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Nicotinamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Nicotinamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Nicotinamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Nicotinamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Nicotinamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Nicotinamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Nicotinamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Nicotinamide Tablets Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Nicotinamide Tablets Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • 50mg/Tablets
  • 100mg/Tablets
Applications
  • Online Sales
  • Offline Sales
Companies covered
  • Puritan’s Pride
  • Swisse
  • CONBA
  • Shanghai Pharma
  • Century Huaxing Biological Engineering
  • Tianjin Lisheng Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Nicotinamide Tablets Sales Value (2021-2032)
  4. 1.2.2 Global Nicotinamide Tablets Sales Volume (2021-2032)
  5. 1.2.3 Global Nicotinamide Tablets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Nicotinamide Tablets Market Dynamics
  1. 2.1 Nicotinamide Tablets Industry Trends
  2. 2.2 Nicotinamide Tablets Industry Drivers
  3. 2.3 Nicotinamide Tablets Industry Opportunities and Challenges
  4. 2.4 Nicotinamide Tablets Industry Restraints
3 Nicotinamide Tablets Market by Company
  1. 3.1 Global Nicotinamide Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Nicotinamide Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Nicotinamide Tablets Sales Volume by Company (2021-2026)
  4. 3.4 Global Nicotinamide Tablets Average Price by Company (2021-2026)
  5. 3.5 Global Nicotinamide Tablets Company Ranking (2024-2026)
  6. 3.6 Global Nicotinamide Tablets Company Manufacturing Base and Headquarters
  7. 3.7 Global Nicotinamide Tablets Company Product Type and Application
  8. 3.8 Global Nicotinamide Tablets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Nicotinamide Tablets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Nicotinamide Tablets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Nicotinamide Tablets Market by Type
  1. 4.1 Nicotinamide Tablets Type Introduction
  2. 4.1.1 50mg/Tablets
  3. 4.1.2 100mg/Tablets
  4. 4.2 Global Nicotinamide Tablets Sales Volume by Type
  5. 4.2.1 Global Nicotinamide Tablets Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Nicotinamide Tablets Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Nicotinamide Tablets Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Nicotinamide Tablets Sales Value by Type
  9. 4.3.1 Global Nicotinamide Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Nicotinamide Tablets Sales Value by Type (2021-2032)
  11. 4.3.3 Global Nicotinamide Tablets Sales Value Share by Type (2021-2032)
5 Nicotinamide Tablets Market by Application
  1. 5.1 Nicotinamide Tablets Application Introduction
  2. 5.1.1 Online Sales
  3. 5.1.2 Offline Sales
  4. 5.2 Global Nicotinamide Tablets Sales Volume by Application
  5. 5.2.1 Global Nicotinamide Tablets Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Nicotinamide Tablets Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Nicotinamide Tablets Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Nicotinamide Tablets Sales Value by Application
  9. 5.3.1 Global Nicotinamide Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Nicotinamide Tablets Sales Value by Application (2021-2032)
  11. 5.3.3 Global Nicotinamide Tablets Sales Value Share by Application (2021-2032)
6 Nicotinamide Tablets Regional Sales and Value Analysis
  1. 6.1 Global Nicotinamide Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Nicotinamide Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Nicotinamide Tablets Sales by Region: 2021-2026
  4. 6.2.2 Global Nicotinamide Tablets Sales by Region (2027-2032)
  5. 6.3 Global Nicotinamide Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Nicotinamide Tablets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Nicotinamide Tablets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Nicotinamide Tablets Sales Value by Region (2027-2032)
  9. 6.5 Global Nicotinamide Tablets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Nicotinamide Tablets Sales Value (2021-2032)
  12. 6.6.2 North America Nicotinamide Tablets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Nicotinamide Tablets Sales Value (2021-2032)
  15. 6.7.2 Europe Nicotinamide Tablets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Nicotinamide Tablets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Nicotinamide Tablets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Nicotinamide Tablets Sales Value (2021-2032)
  21. 6.9.2 South America Nicotinamide Tablets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Nicotinamide Tablets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Nicotinamide Tablets Sales Value Share by Country, 2025 VS 2032
7 Nicotinamide Tablets Country-level Sales and Value Analysis
  1. 7.1 Global Nicotinamide Tablets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Nicotinamide Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Nicotinamide Tablets Sales by Country (2021-2032)
  4. 7.3.1 Global Nicotinamide Tablets Sales by Country (2021-2026)
  5. 7.3.2 Global Nicotinamide Tablets Sales by Country (2027-2032)
  6. 7.4 Global Nicotinamide Tablets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Nicotinamide Tablets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Nicotinamide Tablets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Nicotinamide Tablets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Nicotinamide Tablets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Nicotinamide Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Nicotinamide Tablets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Nicotinamide Tablets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Nicotinamide Tablets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Nicotinamide Tablets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Nicotinamide Tablets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Nicotinamide Tablets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Nicotinamide Tablets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Nicotinamide Tablets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Nicotinamide Tablets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Nicotinamide Tablets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Nicotinamide Tablets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Nicotinamide Tablets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Nicotinamide Tablets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Nicotinamide Tablets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Nicotinamide Tablets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Nicotinamide Tablets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Nicotinamide Tablets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Nicotinamide Tablets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Nicotinamide Tablets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Nicotinamide Tablets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Nicotinamide Tablets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Nicotinamide Tablets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Nicotinamide Tablets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Nicotinamide Tablets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Nicotinamide Tablets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Nicotinamide Tablets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Nicotinamide Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Puritan’s Pride
  2. 8.1.1 Puritan’s Pride Company Information
  3. 8.1.2 Puritan’s Pride Business Overview
  4. 8.1.3 Puritan’s Pride Nicotinamide Tablets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Puritan’s Pride Nicotinamide Tablets Product Portfolio
  6. 8.1.5 Puritan’s Pride Recent Developments
  7. 8.2 Swisse
  8. 8.2.1 Swisse Company Information
  9. 8.2.2 Swisse Business Overview
  10. 8.2.3 Swisse Nicotinamide Tablets Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Swisse Nicotinamide Tablets Product Portfolio
  12. 8.2.5 Swisse Recent Developments
  13. 8.3 CONBA
  14. 8.3.1 CONBA Company Information
  15. 8.3.2 CONBA Business Overview
  16. 8.3.3 CONBA Nicotinamide Tablets Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 CONBA Nicotinamide Tablets Product Portfolio
  18. 8.3.5 CONBA Recent Developments
  19. 8.4 Shanghai Pharma
  20. 8.4.1 Shanghai Pharma Company Information
  21. 8.4.2 Shanghai Pharma Business Overview
  22. 8.4.3 Shanghai Pharma Nicotinamide Tablets Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Shanghai Pharma Nicotinamide Tablets Product Portfolio
  24. 8.4.5 Shanghai Pharma Recent Developments
  25. 8.5 Century Huaxing Biological Engineering
  26. 8.5.1 Century Huaxing Biological Engineering Company Information
  27. 8.5.2 Century Huaxing Biological Engineering Business Overview
  28. 8.5.3 Century Huaxing Biological Engineering Nicotinamide Tablets Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Century Huaxing Biological Engineering Nicotinamide Tablets Product Portfolio
  30. 8.5.5 Century Huaxing Biological Engineering Recent Developments
  31. 8.6 Tianjin Lisheng Pharmaceutical
  32. 8.6.1 Tianjin Lisheng Pharmaceutical Company Information
  33. 8.6.2 Tianjin Lisheng Pharmaceutical Business Overview
  34. 8.6.3 Tianjin Lisheng Pharmaceutical Nicotinamide Tablets Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Tianjin Lisheng Pharmaceutical Nicotinamide Tablets Product Portfolio
  36. 8.6.5 Tianjin Lisheng Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Nicotinamide Tablets Value Chain Analysis
  2. 9.1.1 Nicotinamide Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Nicotinamide Tablets Sales Mode & Process
  6. 9.2 Nicotinamide Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Nicotinamide Tablets Distributors
  9. 9.2.3 Nicotinamide Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst